


Ask a doctor about a prescription for OLMESARTAN TECNIGEN 40 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Olmesartan Tecnigen 40 mg Film-Coated Tablets EFG
Olmesartan Medoxomil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Olmesartan Tecnigen belongs to a group of medicines called angiotensin II receptor antagonists. It lowers blood pressure by relaxing blood vessels.
Olmesartan Tecnigen is used to treat high blood pressure (also known as hypertension). High blood pressure can damage blood vessels in organs such as the heart, kidneys, brain, and eyes. In some cases, this can lead to a heart attack, heart failure, or kidney failure, stroke, or blindness. Usually, high blood pressure does not present symptoms. It is essential to control your blood pressure to avoid damage.
High blood pressure can be controlled with medicines like Olmesartan Tecnigen tablets. Your doctor will probably also recommend that you make some changes in your lifestyle to help lower your blood pressure (e.g., lose weight, stop smoking, reduce the amount of alcohol you drink, and reduce the amount of salt in your diet). Your doctor may also recommend that you exercise regularly, such as walking or swimming. It is crucial to follow this advice from your doctor.
Do not take Olmesartan Tecnigen
Warnings and precautions
Consult your doctor before starting to take Olmesartan Tecnigen.
Tell your doctorif you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may need to check your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the headings “Do not take Olmesartan Tecnigen” and “Warnings and precautions”.
Tell your doctorif you have any of the following health problems:
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking olmesartan. Your doctor will decide whether to continue treatment. Do not stop taking olmesartan on your own.
Contact your doctor if you have severe, persistent diarrhea that causes significant weight loss. Your doctor will assess your symptoms and decide how to proceed with your blood pressure treatment.
As with any other medicine that lowers blood pressure, an excessive drop in blood pressure in patients with impaired blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
You should inform your doctor if you are pregnant or think you might be. Olmesartan Tecnigen is not recommended at the start of pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken at this stage (see section Pregnancy).
Children and adolescents
Olmesartan Tecnigen is not recommended for children and adolescents under 18 years of age.
Using Olmesartan Tecnigen with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Your doctor may need to change your dose and/or take other precautions:
If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Olmesartan Tecnigen” and “Warnings and precautions”).
Elderly patients
If you are over 65 years old and your doctor decides to increase the dose of olmesartan medoxomil to 40 mg per day, your doctor will regularly check your blood pressure to ensure it does not drop too low.
Black patients
As with other similar medicines, the blood pressure-lowering effect of Olmesartan Tecnigen is somewhat less in black patients.
Taking Olmesartan Tecnigen with food and drinks
Olmesartan can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant or think you might be. Your doctor will advise you to stop taking Olmesartan Tecnigen before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Olmesartan Tecnigen. Olmesartan Tecnigen is not recommended in early pregnancy, and it must not be taken when you are more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Breastfeeding
Tell your doctor if you are breastfeeding or about to start breastfeeding. Olmesartan Tecnigen is not recommended for breastfeeding mothers, and your doctor may choose another treatment if you want to breastfeed, especially if your baby is newborn or premature.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
You may feel drowsy or dizzy during treatment for high blood pressure. If this happens, do not drive or use machines until the symptoms have gone away. Consult your doctor.
This medicine contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended initial dose is 1 Olmesartan Tecnigen 10 mg tablet per day. If your blood pressure is not controlled adequately, your doctor may increase the dose to 20 mg or 40 mg per day or prescribe additional treatment.
In patients with mild to moderate kidney problems, the maximum dose is 20 mg once a day.
The tablets can be taken with or without food. Take the tablets with a sufficient amount of water (e.g., a glass). If possible, take your dose at the same time each day, for example, at breakfast time.
If you take more Olmesartan Tecnigen than you should
If you have taken more tablets than you should or if a child has accidentally taken some, contact your doctor or the nearest hospital emergency department immediately and take the medicine pack with you.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 91 562 04 20.
If you forget to take Olmesartan Tecnigen
If you forget to take a dose, take your normal dose the next day. Do not take a double dose to make up for forgotten doses.
If you stop taking Olmesartan Tecnigen
It is essential to continue taking Olmesartan Tecnigen unless your doctor tells you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If they do occur, they are often mild and do not require treatment to be stopped.
The following side effects may be serious, although they are rare.
Rarely (may affect up to 1 in 1,000 people), the following allergic reactions have been reported, which can affect the whole body: swelling of the face, mouth, and/or throat, along with itching and skin rash. If this happens, stop taking Olmesartan Tecnigen and consult your doctor immediately.
Rarely (but slightly more often in elderly patients), Olmesartan Tecnigen may cause a pronounced drop in blood pressure in susceptible patients or as a result of an allergic reaction. This can cause fainting or severe dizziness. If this happens, stop taking Olmesartan Tecnigen, consult your doctor immediately, and remain lying down.
Frequency not known (cannot be estimated from the available data): If you experience yellowing of the whites of the eyes, dark urine, itching of the skin, even if you started treatment with olmesartan a long time ago, contact your doctor immediately, who will assess your symptoms and decide how to proceed with your blood pressure treatment.
These are other known side effects of Olmesartan Tecnigen:
Common side effects (may affect up to 1 in 10 people):
Dizziness, headache, nausea, indigestion, diarrhea, stomach pain, gastroenteritis, fatigue, sore throat, nasal congestion and discharge, bronchitis, flu-like symptoms, cough, pain, chest pain, back pain, bone pain, joint pain, urinary tract infection, swelling of ankles, feet, legs, hands, arms, blood in urine.
Some changes in the results of certain blood tests have also been observed:
increased levels of fat (hypertriglyceridemia), increased levels of uric acid (hyperuricemia), increased urea levels in the blood, increases in liver and muscle function test values.
Uncommon side effects (may affect up to 1 in 100 people):
Rapid allergic reactions that can affect the whole body and cause breathing problems, as well as a rapid drop in blood pressure that can lead to fainting (anaphylactic reactions), swelling of the face, dizziness, vomiting, weakness, feeling unwell, muscle pain, skin rash, allergic skin rash, itching, skin eruption (skin rash), hives (skin swelling), angina (chest pain or discomfort).
In blood tests, a decrease in the number of a type of blood cell called platelets (thrombocytopenia) has been observed.
Rare side effects (may affect up to 1 in 1,000 people):
Lack of energy, muscle cramps, worsening of kidney function, kidney failure.
Some changes in the results of certain blood tests have been observed, including increased levels of potassium in the blood (hyperkalemia) and increased levels of components related to kidney function.
Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Other side effects in children and adolescents:
Similar side effects to those reported in adults have been observed in children. However, dizziness and headache have been reported more frequently in children, and nosebleeds are a common side effect observed only in children.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister (after “EXP.”). The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Olmesartan Tecnigen contains
The active substance is olmesartan medoxomil.
Each film-coated tablet contains 40 mg of olmesartan medoxomil.
The other ingredients are lactose monohydrate, low-substituted hydroxypropylcellulose, hydroxypropylcellulose, microcrystalline cellulose, and magnesium stearate.
The coating contains hypromellose, titanium dioxide (E171), lactose monohydrate, macrogol 3350, and triacetin.
Appearance and packaging
Olmesartan Tecnigen 40 mg are white, oval, biconvex film-coated tablets with the inscription OL40 on one side.
This medicine is available in packs of 28 tablets.
Marketing Authorisation Holder
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid)
Spain
Manufacturer
Actavis Ltd.,
BLB 016 Bulebel Industrial Estate,
Zejtun ZTN 3000,
Malta
Date of last revision of this leaflet:February 2025
Detailed and up-to-date information on this medicine is available on the website of the Spanish Medicines and Healthcare Products Agency (AEMPS) http://www.aemps.gob.es/
The average price of OLMESARTAN TECNIGEN 40 mg FILM-COATED TABLETS in October, 2025 is around 20.17 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLMESARTAN TECNIGEN 40 mg FILM-COATED TABLETS – subject to medical assessment and local rules.